Live Breaking News & Updates on Quralis Corporation

Stay updated with breaking news from Quralis corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

QurAlis to Present at H.C. Wainwright BioConnect 2022 Virtual Conference

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other. ....

United Kingdom , Kasper Roet , Hc Wainwright Bioconnect , Quralis Corporation , Bioconnect Virtual Conference ,

QurAlis Announces Publication in Molecular Biology of the Cell of Next Generation Drug Screening Platform for ALS Developed by Company Founders

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other. ....

United States , United Kingdom , Harvard University , Kasper Roet , Clifford Woolf , Kevin Eggan , Broad Institute , Amazon Web Services , Quralis Corporation , Molecular Biology , Boston Children , Bruno Boivin , Anne Carpenter ,

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other. ....

United Kingdom , Jason Bussgang , Erika Norabuena , Yasmin Hamwi , James Chow , Kevin Eggan , Qurali Asos , Sandy Hinckley , Marisa Kamelgarn , Daniel Elbaum , Taylor Gray , International Symposium , Quralis Corporation , Eggan Lab , Time Course , Protein Abundance , Golgi Apparatus Morphology , Neurite Outgrowth , Proteotoxic Stress , Human Induced Pluripotent Derived Motor , Abstract Number , Qurali Chief Scientific Officer , Patient Stratification , Target Engagement , Hafiz Mohmmadabdul , Rapid Generation ,

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

United Kingdom , Jason Bussgang , Erika Norabuena , Yasmin Hamwi , James Chow , Kevin Eggan , Qurali Asos , Sandy Hinckley , Marisa Kamelgarn , Daniel Elbaum , Taylor Gray , Harvard University , International Symposium , Harvard Medical School , Eggan Lab , Quralis Corporation , Prnewswire Quralis Corporation , Alis Corporation , Time Course , Protein Abundance , Golgi Apparatus Morphology , Neurite Outgrowth , Proteotoxic Stress , Human Induced Pluripotent Derived Motor Neurons , Abstract Number , Qurali Chief Scientific Officer ,

QurAlis Presents New Data Confirming Role of STATHMIN-2 in Neuronal Disease Biology at 32nd International Symposium on ALS/MND

/PRNewswire/ QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other. ....

United Kingdom , Jason Bussgang , Erika Norabuena , Yasmin Hamwi , James Chow , Kevin Eggan , Qurali Asos , Sandy Hinckley , Marisa Kamelgarn , Daniel Elbaum , Taylor Gray , International Symposium , Quralis Corporation , Eggan Lab , Time Course , Protein Abundance , Golgi Apparatus Morphology , Neurite Outgrowth , Proteotoxic Stress , Human Induced Pluripotent Derived Motor , Abstract Number , Qurali Chief Scientific Officer , Patient Stratification , Target Engagement , Hafiz Mohmmadabdul , Rapid Generation ,